Nutrition Counter

Reducing the amount of phosphorus in your diet is one of the keys to controlling hyperphosphatemia. It’s not always easy. Phosphorus is found in almost everything you eat, and some foods contain more than others.

Because nutritional knowledge is a vital part of phosphorus control, Shire, the maker of FOSRENOL®, worked with the American Association of Kidney Patients (AAKP) to sponsor the creation of a nutrition counter specifically geared to kidney disease patients.

Easy-to-use, the AAKP Nutrition Counter lists sodium, potassium, phosphorus, protein and calorie counts for a wide range of basic cooking ingredients, fresh fruits and vegetables, beverages, snack foods and ready-to-eat foods, such as bagels and croutons. Fast foods from national chain restaurants are also included in this 24-page booklet.

Download the Nutrition Counter now.

In addition to watching your phosphorus intake, it is important to take FOSRENOL® as directed by your doctor.

The most common adverse events were gastrointestinal, such as nausea and vomiting, and generally went away over time with continued dosing.

Important Safety Information
  • During clinical trials, the most common side effects of FOSRENOL were gastrointestinal, and included nausea, vomiting, and diarrhea. Nausea and vomiting generally lessened over time as patients continued with their treatment.
  • Patients who stopped treatment usually reported gastrointestinal side effects as the reason for stopping. Other side effects reported in trials included dialysis graft complications, headache, abdominal pain, and low blood pressure.
  • Although studies were not designed to detect differences in risk of bone fracture and mortality, there were no differences demonstrated in patients treated with FOSRENOL compared to alternative therapy for up to 3 years.
  • The duration of treatment exposure and time of observation in the clinical program were too short to conclude that FOSRENOL does not affect the risk of bone fracture or mortality beyond 3 years.
  • While lanthanum has been shown to accumulate in the GI tract, liver, and bone in animals, the clinical significance in humans is unknown.
  • If you suffer from acute stomach ulcer, colon inflammation and colon ulcers, Crohn's disease, or bowel obstruction, it is important to know that patients with these conditions were not included in FOSRENOL clinical studies — please discuss with your doctor.
  • Don't take FOSRENOL if you are nursing or pregnant, or if you are under 18 years of age.

Shire
©2008 Shire US Inc., Wayne, PA 19087-5367
(800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

FOS-00086 08/08